The creation of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, requires a complex multi-step chemical process. Preliminary routes focused on peptide section coupling, utilizing solid-phase synthesis methodologies to build the long amino acid sequence. Subsequent research has explored various approaches, including enz… Read More